Evoke Pharma Inc.
12/18/2025 | Press release | Distributed by Public on 12/19/2025 05:05
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322662 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Evoke Pharma Inc. published this content on December 18, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 19, 2025 at 11:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]